What are the considerations for labetalol use in patients with systemic lupus erythematosus, particularly regarding disease activity and medication interactions?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Patients with systemic lupus erythematosus (SLE) taking labetalol need monitoring for exacerbation of SLE symptoms and drug interactions, especially with immunosuppressants.